@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix ns1: <http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:> .
@prefix ns2: <http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:mjrr9vvj&rows=> .
@prefix ns3: <https://uts.nlm.nih.gov/uts/umls/semantic-network/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RAZpPh-bFa9LifSsgVDfk6ayEFVEPI_Isqi1Su-maQ7rw#> .
@prefix this: <http://purl.org/np/RAZpPh-bFa9LifSsgVDfk6ayEFVEPI_Isqi1Su-maQ7rw> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   <https://uts.nlm.nih.gov/uts/umls/concept/C0304231> ns3:T155 <https://uts.nlm.nih.gov/uts/umls/concept/C1533734> .
}
sub:provenance {
   sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" , "S&T TWOC version 3" .
  sub:_version prov:value 2 .
  sub:assertion prov:generatedAtTime "2023-07-20T09:47:32.345705"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0003-4692-1377 ;
    prov:wasDerivedFrom <https://www.ncbi.nlm.nih.gov/pubmed/33907514/> .
  rdf:OBJECT rdfs:label "in the treatment of COVID-19" .
  rdf:OBJECT-POSITION rdfs:label "(51, 69)" .
  rdf:PREDICATE rdfs:label "used" .
  rdf:PREDICATE-POSITION rdfs:label "70" .
  rdf:SUBJECT rdfs:label "therapeutic agents" .
  rdf:SUBJECT-POSITION rdfs:label "(51, 69)" .
  rdf:Statement rdfs:label "Furthermore, the potential Treg-boosting effect of therapeutic agents used in the treatment of COVID-19, including dexamethasone, vitamin D, tocilizumab and sarilumab, chloroquine, hydroxychloroquine, azithromycin, adalimumab and tetrandrine, is discussed." .
  rdfs:ABSTRACT-UID ns2:50 "mjrr9vvj" .
  rdfs:TRIPLE-UID ns1:mjrr9vvj-TRIPLE-ABSTRACT-2 "mjrr9vvj-TRIPLE-ABSTRACT-2" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C0304231> rdfs:label "therapeutic agents" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C1533734> rdfs:label "treatment" .
}
sub:pubinfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "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" ;
    npx:hasSignature "HdVgNerhosEAZtlo437Tcp40A2ppyOFqG9uDugl+02kYHxSGKRiAv8REiCngG1Puxjrtzbu1b4yisFQ/zU0kLlNeUfpGtb8wOc0bumbVzwmrw2o+OajaOXrkg1XLFXwdaNYMLDZHiI0FRh9CBRG8cY1tA3SE0+t1JpXVctm9mNktB+bdVjHRCXwK9rrw9o8Ikcdjwl0nlfYj6M8hqkyWii9z1UKWsv1mBSzZ2cV6e4dxtGET4JXd3hzUtnP3vQ6sum0PHSnADS7wmzjEAKaIKxeaA1V2XguVA+66AYTVldt/dOcWLgT4bdzSXYuOGU1o+TfOwf6yp6fymbopbmwuM1qc9+t/p1Sb1zzFQBNl3hGPibNyge582HIzBVBjpIPLk6QdD9Mkv2uaLE3SACYJXZ2ebsmiJcPNQ2HN8j6aprTwjP4jp/HVM33G4O03Ex6do1F/Y6u6DXbL747mr+jP/LLyVUK97SEmFS+1OgELiMQia+g5wiyfMhgV8h9rz/cO" ;
    npx:hasSignatureTarget this: .
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}